Join to View Full Profile
1500 , 17th FloorNew York, NY 10036
Phone+1 302-463-1699
Fax+1 610-422-5446
Dr. Shalaby is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Pennsylvania Health SystemFellowship, Gynecologic Oncology, 2000 - 2003- University of Pennsylvania Health SystemResidency, Obstetrics and Gynecology, 1996 - 2000
Medical University of South CarolinaClass of 1996
Purdue UniversityPhD, Pharmaceutics, 1988 - 1992
Certifications & Licensure
PA State Medical License 1999 - 2018
DE State Medical License Active through 2013
Publications & Presentations
PubMed
- Prognostic Value of Fibroblast Growth Factor Receptor Genetic Alterations in Metastatic Urothelial Carcinoma.Sarah Fleming, Dina Gifkins, Helaine E Resnick, Waleed Shalaby, Philip Rosenberg
Clinical Genitourinary Cancer. 2024-06-01 - 9 citationsCardiac safety of trabectedin monotherapy or in combination with pegylated liposomal doxorubicin in patients with sarcomas and ovarian cancer.Robin L. Jones, Thomas J. Herzog, Shreyaskumar Patel, Margaret von Mehren, Scott M. Schuetze
Cancer Medicine. 2021-05-07 - 2 citationsData on Prior Pegylated Liposomal Doxorubicin (PLD) Treatment in Recurrent Ovarian Cancer: Post-hoc Data Analysis From the Phase 3 Randomized, Open-label Study Compari...Bradley J. Monk, Thomas J. Herzog, George Wang, Spyros Triantos, Scott Maul
Data in Brief. 2020-03-20
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
